Invitrogen™ Lipofectamine™ CRISPRMAX™ Cas9 Transfection Reagent

Description

Lipofectamine CRISPRMAX Cas9 Transfection Reagent is the first optimized lipid-based transfection reagent for CRISPR knockout applications. It effectively delivers the Cas9 protein and guide RNA (gRNA) ribonucleoprotein (RNP) complex, ensuring high transfection efficiency and effective gene knockout. The proprietary lipid-based transfection reagent minimizes cellular toxicity, making it suitable to for sensitive cells. Its ease of use and compatibility with high-throughput screening make it a cost-effective alternative to electroporation.

Combined with our TrueCut Cas9 Protein v2 and TrueGuide Synthetic gRNA, it provides:

• Optimized for CRISPR—specially formulated for CRISPR-Cas9 RNP applications
• Superior gene knockout—efficient Cas9 transfection ensures higher genomic cleavage
• Broad cell type applicability—versatile for use in a wide range of cell lines, including primary cells and stem cells
• Minimal cytotoxicity—viable, healthy cells maintained throughout Cas9 transfection
• High-throughput compatible—an ideal delivery solution for functional genomic studies with CRISPR-Cas9

Achieve high transfection efficiency in novel genome editing applications

Lipofectamine CRISPRMAX Transfection Reagent enables successful Cas9 transfection in a wide range of cell types, including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and more. Unlike CRISPR plasmid or Cas9 mRNA, this protein-based approach eliminates the need for transcription or translation, reducing the risk of genomic integration and making the process cell cycle-independent. When combined with our TrueCut Cas9 Protein v2 and TrueGuide Synthetic gRNA, it ensures superior cleavage efficiency and effective gene editing.